Altering the immune system to reverse paralysis

April 3, 2017
Researchers have developed an immunotherapy that, when given to paralyzed mice exhibiting a mouse model of multiple sclerosis (left), the mice regained the ability to walk (right) . Credit: American Chemical Society

In the ultimate betrayal, one's own immune system can turn against the protective sheath that envelops neurons in the brain, leaving the body paralyzed. Researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning the power of movement to paralyzed mice. The approach may someday combat autoimmune diseases, such as multiple sclerosis and type 1 diabetes, in humans.

The researchers will present their work today at the 253rd National Meeting & Exposition of the American Chemical Society (ACS).

"The problem with current immunotherapies is that they aren't specific," says Christopher Jewell, Ph.D. "They act broadly, compromising the entire immune system and putting the patient's health at risk, rather than focusing on only those doing the damage."

By considering how the immune system works, Jewell's team at the University of Maryland set their sights on the as a possible target for creating a . In autoimmune disease, a body-roaming immune cell recognizes an antigen—a molecule that the cell in this case falsely identifies as a piece of a foreign invader—and brings it to the lymph nodes, where another type of immune cell, the T cell, is then programmed to attack the antigen. For example, in , T cells are taught to recognize and attack the myelin sheath. Jewell thought it might be possible to prevent the T cells from learning bad habits by delivering an immune-system modifying agent directly to the lymph nodes.

The video will load shortly

To build the immunotherapeutic agent, the researchers first constructed a particle from poly(lactide-co-glycolide), an FDA-approved polymer, to serve as a carrier. They infused it with an immune-suppressing agent and the myelin antigen, to teach the T cells that myelin is no enemy.

The researchers injected these particles into the lymph nodes of paralyzed mice exhibiting a mouse model of multiple sclerosis. The particles slowly reprogrammed the environment of the lymph node tissues to generate that migrated to the brain to stop the attack against myelin. These mice regained the ability to walk, and the effects lasted for the duration of the study, which was about 80 days. The mice were also able to readily respond when foreign molecules were introduced, suggesting that the treatment didn't compromise normal immune function.

As a next step, the researchers have been testing the idea in other mouse models of autoimmune disease, including transplant models and models of type 1 diabetes—a disease in which the immune system attacks the pancreas. Later this year, the group will team up with clinicians at the University of Maryland Medical School to begin tests in non-human primates, another step closer to investigating this idea as a future human therapy.

Explore further: Biomedical researchers break new ground in fight against multiple sclerosis

More information: Harnessing biomaterials to study and engineer lymph node function, the 253rd National Meeting & Exposition of the American Chemical Society (ACS), 2017.

Related Stories

Research reveals how lymph nodes expand during disease

October 22, 2014

Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, according to a study published ...

Solving a genetic mystery in type 1 diabetes

April 11, 2016

In type 1 diabetes, the immune system attacks the body's own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don't understand what triggers the attack or how ...

Recommended for you

Experts uncover first molecular events of organ rejection

June 23, 2017

Researchers at the University of Pittsburgh School of Medicine and the University of Toronto have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.